General Information of Drug (ID: DMQI1EW)

Drug Name
ARO-RAGE Drug Info
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMQI1EW

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Advanced glycosylation end product-specific receptor messenger RNA (AGER mRNA) TTDUDE4 RAGE_HUMAN Antagonist [2]

References

1 ClinicalTrials.gov (NCT05533294) A Phase 1 Study Evaluating the Effects of ARO-RAGE Injection for Subcutaneous Administration in Healthy Subjects. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Arrowhead Pharmaceuticals